Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Baudin

Showing results (81-90 of 129) with videos related to

Pageof 13
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 23, 2022
Corrigendum to "Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology volume 31 (2020) 1476-1490]M Fassnacht, G Assie, E Baudin, et al.
British Journal of Cancer|October 29, 1998
Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumoursE Baudin, A Gigliotti, M Ducreux, et al.
The Journal of Clinical Endocrinology and Metabolism|May 11, 2006
Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapyC Durante, N Haddy, E Baudin, et al.
British Journal of Cancer|December 22, 1999
Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatinE Mitry, E Baudin, M Ducreux, et al.
Endocrine-Related Cancer|December 2, 2010
Do histological, immunohistochemical, and metabolic (radioiodine and fluorodeoxyglucose uptakes) patterns of metastatic thyroid cancer correlate with patient outcome?D Deandreis, A Al Ghuzlan, S Leboulleux, et al.
Annales D'Endocrinologie|April 6, 1999
[Von Hippel-Lindau disease: recent genetic progress and patient management. Francophone Study Group of von Hippel-Lindau Disease (GEFVH)]S Richard, S Giraud, C Beroud, et al.
Antimicrobial Agents and Chemotherapy|March 26, 2014
Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatmentN B Bhatt, C Barau, A Amin, et al.
The Journal of Clinical Endocrinology and Metabolism|September 24, 2013
Comparison of two mitotane starting dose regimens in patients with advanced adrenocortical carcinomaT M Kerkhofs, E Baudin, M Terzolo, et al.
European Journal of Endocrinology|November 27, 1999
Early or prophylactic thyroidectomy in MEN 2/FMTC gene carriers: results in 71 thyroidectomized patients. The French Calcitonin Tumours Study Group (GETC)P Niccoli-Sire, A Murat, E Baudin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2015
Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoidsM E Caplin, E Baudin, P Ferolla, et al.
Pageof 13

Showing results (81-90 of 129) with videos related to

Sort By:
Pageof 13
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 23, 2022
Corrigendum to "Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology volume 31 (2020) 1476-1490]M Fassnacht, G Assie, E Baudin, et al.
British Journal of Cancer|October 29, 1998
Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumoursE Baudin, A Gigliotti, M Ducreux, et al.
The Journal of Clinical Endocrinology and Metabolism|May 11, 2006
Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapyC Durante, N Haddy, E Baudin, et al.
British Journal of Cancer|December 22, 1999
Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatinE Mitry, E Baudin, M Ducreux, et al.
Endocrine-Related Cancer|December 2, 2010
Do histological, immunohistochemical, and metabolic (radioiodine and fluorodeoxyglucose uptakes) patterns of metastatic thyroid cancer correlate with patient outcome?D Deandreis, A Al Ghuzlan, S Leboulleux, et al.
Annales D'Endocrinologie|April 6, 1999
[Von Hippel-Lindau disease: recent genetic progress and patient management. Francophone Study Group of von Hippel-Lindau Disease (GEFVH)]S Richard, S Giraud, C Beroud, et al.
Antimicrobial Agents and Chemotherapy|March 26, 2014
Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatmentN B Bhatt, C Barau, A Amin, et al.
The Journal of Clinical Endocrinology and Metabolism|September 24, 2013
Comparison of two mitotane starting dose regimens in patients with advanced adrenocortical carcinomaT M Kerkhofs, E Baudin, M Terzolo, et al.
European Journal of Endocrinology|November 27, 1999
Early or prophylactic thyroidectomy in MEN 2/FMTC gene carriers: results in 71 thyroidectomized patients. The French Calcitonin Tumours Study Group (GETC)P Niccoli-Sire, A Murat, E Baudin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2015
Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoidsM E Caplin, E Baudin, P Ferolla, et al.
Pageof 13